bpc-157 compounding restrictions fda Discusses Peptide Bulk Substances and More | Hillary Lin, MD posted on the topic FDA advisory committee votes to
FDA advisory committee votes to add popular peptide BPC 157 to drug compounding list ABC News Repost @peptides with @use.repost BREAKING NEWS! Today's 86 advisory vote for BPC 157 is one of the biggest peptide regulatory developments we've seen in years. While nothing changes immediately, the recommendation represents Hims & Hers Stock Jumps as FDA Panel Opens the Door to a Multibillion Dollar Peptide Market PRISM MarketView FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline What to Know About Peptides the FDA Is Considering for Use The New York Times Big win for $HIMS. The FDA advisory panel voted to allow compounding of BPC 157, KPV, TB 500 and MOTS C, opening the door to a multibillion dollar peptide market. Hims is positioned to capitalize.
Pay in 4 interest-free payments of $7.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



